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OBJECTIVES The purpose of the study was to assess the long-term outcome of patients with small
ventricular septal defects (VSDs) considered not to require surgical closure during childhood.
BACKGROUND Although patients with small VSDs have generally been considered not to require surgery,
more recent data suggest that a significant percentage of these patients develop serious
problems during adult life.
METHODS A total of 229 consecutive patients (115 females) with a VSD considered too small to require
surgery during childhood as defined by normal pulmonary artery pressure, less than 50%
shunt, pulmonary vascular resistance 200 dynesscm5, no VSD-related aortic regurgita-
tion (AR), and no symptoms and who had no additional hemodynamically relevant heart
defect were followed in an adult congenital heart disease program. Physical examination,
electrocardiography, and echocardiography were performed in all patients in one- to
three-year intervals; exercise tests and Holter monitoring were performed in 140 and 127
patients, respectively.
RESULTS Follow-up was completed in 222 patients (97%). Mean age at last visit was 30  10 years.
Spontaneous VSD closure was observed in 14 patients (6%). No patients died, four patients
(1.8%) had an episode of endocarditis, of whom two required aortic valve replacement, and
one additional patient (0.4%) had surgical closure for hemodynamic reasons. For 118 patients
who entered the study between 1993 and 1996 and were prospectively followed for 7.4  1.2
years, event-free survival with end points defined as death, endocarditis or heart surgery was
99.1  0.8% at three years, 96.5  1.7% at six years and 95.5  1.9% at eight years. At last
visit, 94.6% of all patients studied were symptom free. Left ventricular (LV) size by
echocardiography was normal in 198 (89%) patients, borderline in 23 patients and definitely
enlarged in only one patient. None had systolic LV dysfunction, and pulmonary artery
pressure (PAP) was normal in all patients. Mean exercise capacity was 92 21% of expected,
and 87% of patients had no arrhythmias on Holter monitoring, with the remainder showing
benign rhythm disorders.
CONCLUSIONS Outcome in well-selected patients with a small VSD is good. Surgical closure does not appear
to be required during childhood as long as left-to-right shunt is 50% and signs of LV
volume overload are absent, when PAP is not elevated, and no VSD-related AR or symptoms
are present. (J Am Coll Cardiol 2002;39:1066–71) © 2002 by the American College of
Cardiology Foundation
It had been well accepted for many years that patients with
a small ventricular septal defect (VSD) as defined by a
left-to-right shunt of 50%, normal pulmonary artery
pressure (PAP), and absence of symptoms do not require
surgical repair (1–5). Such criteria for operation were based
on the observation that VSDs frequently close spontane-
ously (1,4–6), that patients with such small defects are
unlikely to develop pulmonary hypertension (3,4,7) and that
the clinical outcome was assumed to be good (1,3,4,7).
However, more recent studies that followed patients with
“small” VSDs into adulthood reported a worrying rate of
complications such as endocarditis (8,9), congestive heart
failure (8), development of significant aortic regurgitation (AR)
(8,9), occurrence of arrhythmias and even sudden death (2,8,9).
These observations raised the question of whether criteria for
surgical repair of small VSDs should be more liberal than
previously thought, particularly as the surgical risk in these
patients is now considered to be very low (10). However,
presently available data are limited by small patient numbers
(8) and, probably, selection bias (8,9). In addition, patients in
these previous studies were not followed on a regular basis in a
specialized congenital cardiac center. Therefore, we report the
outcome in a large unselected group of adolescents and adults
with VSDs considered too small to require surgery during
childhood and who were regularly followed in our adult
congenital heart disease program.
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METHODS
Patient population. The patient population consisted of
229 consecutive patients with small VSDs (female/male
115/114). All patients fulfilled the following inclusion
criteria: 1) Surgical closure had not been performed during
childhood for the following reasons: normal PAP, Qp/Qs
2 (50% shunt), pulmonary vascular resistance 200
dynesscm5, no VSD-related AR and no symptoms; and
2) no additional hemodynamically relevant heart defect was
present. The patient population represents the total number
of patients followed in the congenital heart disease program
of the Department of Cardiology, University of Vienna;
patients fulfilled these criteria at their first visit to the
Cardiology Department. The adult congenital heart disease
unit was established in 1993, and it presently follows
approximately 6,500 patients. Most patients had been trans-
ferred directly from the Department of Pediatric Cardiol-
ogy; this normally happens at an age between 14 and 18
years. Patients with episodes of endocarditis, arrhythmias or
other cardiac problems prior to their first visit were not
excluded from the study.
Study protocol. At first visit, the study protocol included
patient history, physical examination, 12-lead electrocardio-
gram (ECG) and transthoracic echocardiography. These
examinations were repeated in one- to three-year intervals.
Since 1997, all patients were asked at their regular visit to
have at least one bicycle exercise test and 24-h Holter
monitoring during follow-up. These tests were eventually
performed in 140 and 127 patients, respectively.
Echocardiography. All echocardiograms were performed
and interpreted at one laboratory. Standard transthoracic
M-mode, two-dimensional and Doppler echocardiography
were performed with commercially available ultrasound
systems. The VSDs were classified by their location into
perimembranous, inlet, outlet supracristal, outlet infracris-
tal, and trabecular. A left ventricular end-diastolic diameter
(LVEDD) 57 mm was considered abnormal. For a
patient size below average, the LVEDD index (LVEDDi)
was also taken into account (30 mm/m2). A fractional
shortening of 28% was considered abnormal. The peak
pressure difference between right and left ventricle (LV) was
calculated from the continuous-wave Doppler-measured
maximum VSD jet velocity using the simplified Bernoulli
equation. Systolic right ventricular-to-right atrial pressure
difference was calculated from the continuous-wave
Doppler-measured peak tricuspid regurgitant velocity with
the simplified Bernoulli equation. When pulmonary steno-
sis was excluded, systolic PAP was obtained by adding 5
mm Hg for the right atrial pressure as long as the gradient
did not indicate pulmonary hypertension and tricuspid
regurgitation was not hemodynamically relevant. A systolic
PAP 32 mm Hg was considered normal. If no adequate
Doppler signal of the tricuspid regurgitant flow could be
obtained, PAP was calculated by subtracting the left ven-
tricular to right ventricular systolic gradient (LV-RV gra-
dient) from the systemic arterial pressure measured with
cuff, provided that no aortic stenosis was present.
Aortic stenosis was classified mild or moderate as long as
the aortic valve area was 1.0 cm2. Patients with an aortic
valve area 1 cm2 were excluded. Aortic, mitral and
tricuspid regurgitation were semiquantified using color
Doppler and pulsed-wave Doppler (trace, mild, moderate
and severe).
24-h Holter monitoring and exercise test. Two-channel
recording was used for 24-h Holter monitoring. Exercise
capacity was evaluated with a bicycle exercise test using
the standard protocol of the Austrian Society of Cardi-
ology and was indicated in percent of expected capacity
(11).
Follow-up. Ever since the establishment of the adult con-
genital heart disease program in 1993, patients were pro-
spectively followed. Patients were seen in one- to three-year
intervals. Besides careful patient history and physical exam-
ination, ECGs and echocardiograms were repeated at each
visit. In 1993, all patients with small VSDs registered in the
database of the Department of Cardiology were invited to a
follow-up visit. If patients did not return to the appointed
visit at this time or during the later prospective follow-up,
they were contacted. If patients could not be reached, their
relatives and their physician were contacted to find out
about patient outcome.
For the assessment of outcome, the following events were
defined: 1) major events: death, culture-positive endocardi-
tis, surgical VSD closure; and 2) minor events: symptoms of
congestive heart failure requiring medical therapy, arrhyth-
mias requiring medical therapy, hospitalization for cardiac
disease related to the VSD.
Statistical analysis. Descriptive data are given as means 
SD. For the descriptive presentation, all patients seen
between 1993 and 2001 were included, and the available
follow-up data before establishment of the special program
were also considered (retrospective data).
For all patients who were recruited during the first four
years of the adult congenital heart disease program (i.e.,
1993 to 1996) and who were prospectively followed until
2001, event-free survival was analyzed by the Kaplan-Meier
method (12).
Abbreviations and Acronyms
AR  aortic regurgitation
ECG  electrocardiogram
LV  left ventricle/ventricular
LVEDD  left ventricular end-diastolic diameter
LVEDDi  left ventricular end-diastolic diameter
index
LV-RV gradient  left ventricular to right ventricular
systolic gradient
PAP  pulmonary artery pressure
Qp/Qs  shunt ratio (pulmonary to systemic
flow)
VSD  ventricular septal defect
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RESULTS
Follow-up was completed in 222 patients (97%). Mean age
at the last visit was 30  10 years. The age distribution of
the study population is shown in Figure 1. Mean follow-up
of the entire study group (including retrospective data) was
7.4  7.3 years. The longest follow-up was 29 years.
Thirty-one percent of the patients were under surveillance
for more than 10 years, and 9% of patients were followed for
more than 20 years.
Defect locations were as follows: perimembranous, 194
(84.8%); trabecular, 30 (13.1%); outlet infracristal, 4 (1.7%);
inlet, 1 (0.4%). Forty-two patients (18%) presented at
follow-up with an aneurysm of the membranous septum.
Spontaneous closure of the VSD during follow-up was
observed in 14 patients (6%) at an age of 21.5  5.6 years
(range, 17 to 31 years).
Mortality and Morbidity
Mortality. No patients died during follow-up.
Endocarditis. Four patients (1.8%) had an episode of
endocarditis at age 24, 27, 34 and 55 years, respectively. All
of them had a perimembranous defect. One patient with
bicuspid aortic valve developed aortic valve endocarditis and
required valve replacement. A Ross procedure was success-
fully performed. A second patient suffered endocarditis of a
tricuspid aortic valve and received a homograft. The other
two patients had mitral valve endocarditis and were treated
medically. One of these patients had mitral valve prolapse.
Surgical closure of the VSD. In the two patients with
endocarditis who required aortic valve replacement, the
VSD was closed at the same time. Another patient required
surgical repair of a ruptured sinus of Valsalva aneurysm
when he was 27 years old and the VSD was closed. Only
one patient underwent surgery for the VSD itself during
follow-up. During childhood, her defect was considered too
small to require surgery. When she was first seen in our
outpatient clinic at age 35 she was still asymptomatic, but
echocardiography suggested LV volume overload
(LVEDDi 39 mm/cm2). By echocardiography, a maximal
defect diameter of approximately 5 mm was measured.
Heart catheterization revealed a Qp/Qs of 2:1. The PAP
was normal (28/10/17 mm Hg). Based on these data,
elective surgical closure was eventually performed. Surgery
was successful in all patients, and no complications oc-
curred.
Event-free survival during prospective follow-up. The
118 patients who were seen during the first four years of the
congenital heart disease program (i.e., 1993 to 1996) were
prospectively followed until 2001 (7.4  1.2 years). Their
age at entry was 20.8  8.1 years. Follow-up was 96%
complete. Event-free survival with end points defined as
death, endocarditis or heart surgery was 99.1  0.8% at
three years, 96.5  1.7% at six years and 95.5  1.9% at
eight years (Fig. 2).
Requirement of medical treatment or hospitalization. In
addition to those patients who had endocarditis or surgery,
no patient was admitted to a hospital for cardiac problems
related to the VSD during follow-up. No patient required
treatment for congestive heart failure. Two patients were on
antiarrhythmic drugs (sotalol and verapamil) for supraven-
tricular arrhythmias. They became symptomatic at 24 and
45 years, respectively. Seven patients required medical
treatment for arterial hypertension (angiotensin-converting
enzyme inhibitors, beta-blockers and/or diuretics); two of
them were also on lipid-lowering drugs. Hypertension was
detected at a mean age of 40.0  11.6 years.
Patient Presentation at Last Follow-up
Clinical presentation. At their last visit, 210 patients
(94.6%) were free of symptoms; 8 patients (3.6%) com-
plained of mild exertional shortness of breath and 4 patients
(1.8%) reported atypical chest pain.
Electrocardiography. In one patient, the ECG showed
permanent regular ventricular pacing. Pacemaker implanta-
tion in this patient had been performed before study entry.
Of the remaining 221 patients, 215 presented with normal
heart axis, while 6 patients had left axis deviation.
Incomplete right bundle branch block was present in 23
Figure 1. Age distribution of patients at their last visit.
Figure 2. Kaplan-Meier event-free survival of 118 prospectively followed
patients with study entry between 1993 and 1996. Events were defined as
death, endocarditis or surgery.
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patients, complete right bundle branch block was present in
2 patients, and complete left bundle branch block in 1
patient. No first-degree or higher-degree heart block was
found in any patient. Of three patients with signs of LV
hypertrophy, two had arterial hypertension.
Echocardiography. Considering both LVEDD and
LVEDDi, the LV was found to be definitely enlarged in
only one patient. This patient also developed symptoms
(limited exercise capacity) and is currently being more
closely evaluated for eventual surgical repair. The LV size
was borderline in 23 patients but without significant change
during follow-up. The remaining 198 patients (89%) had
normal LV size. All patients had normal LV function. The
PAP could not be estimated in five patients for technical
reasons. In 217 patients with available data, systolic PAP
was normal. Additional echocardiographic findings were
AR in 12 patients (trace in 7, mild in 5), bicuspid aortic
valve in 3 patients, moderate aortic stenosis in 1 patient,
aortic valve replacement (autograft, homograft) in 2 pa-
tients, mild mitral regurgitation in 46 patients, mild tricus-
pid regurgitation (more than physiologic) in 6 patients, mild
pulmonary stenosis in 1 patient and double-chambered
right ventricle (gradient 50 mm Hg) in 5 patients.
Exercise Testing and Holter Monitoring
In the 140 patients (63%) who underwent bicycle exercise
testing, mean exercise capacity was 92  21% of expected
(Fig. 3). More than 75% of the patients had an exercise
capacity 80% of expected, and only 14 patients (10%) had
an exercise capacity below 70%. Thirty-six patients had an
exercise capacity greater than 100% (100% to 166%).
Twenty-four hour Holter monitoring could be performed
in 127 patients (57.2%). Of these, 111 patients (87%) had
no pathologic findings. Frequent premature atrial beats
(1%) could be detected in four patients (3%) and supraven-
tricular tachycardia in two patients, with atrioventricular-
node–re-entrant tachycardia in one patient. Ventricular ar-
rhythmias such as bigeminy, couplets or triplets were found in
nine patients (7%).
DISCUSSION
In this large group of 222 patients with small VSDs the
outcome was excellent: The vast majority of patients re-
mained free of any symptoms; AR rarely developed, being
present in only 5% at last follow-up and trivial or mild in all
instances; endocarditis was infrequent with 1.8%; arrhyth-
mias were found in only 13% and were benign in all
patients. This outcome is remarkably better than that
recently reported by two other groups of investigators (8,9).
However, in both previous studies there is a high likelihood
of a selection bias. The population studied by Otterstad et
al. (8) comprises patients who were referred for evaluation of
possible cardiac surgery from all over Norway. Thus, it is
likely that the spectrum of disease severity differed from that
in our population. The fact that half the patients had mild
symptoms such as exercise dyspnea or chest discomfort
whereas ours were all asymptomatic during childhood ap-
pears to support this assumption. In the study reported by
Neumayer et al. (9), patients were at least partially referred
to this special unit because of complications such as endo-
carditis or because of complaints. In addition, they included
patients who had neither heart catheterization nor echocar-
diography. In contrast, most patients in our study were
transferred from the Department of Pediatric Cardiology
within the same institution. The policy is that all patients
are sent to the adult unit regardless of how small the defect
is. In addition, patients in whom surgery is withheld are
carefully selected: They must have small shunts (Qp/Qs
definitely 2.0), normal PAP, no signs of LV volume
overload, no VSD-related AR or aortic cusp prolapse, and
no symptoms. Finally, all patients with small VSDs are
followed in the adult congenital cardiac disease program on
a regular basis. It has to be emphasized that the results of
the present study may only apply to such carefully selected
low-risk patients.
Mortality. Although we had no mortality in our study, 11
of 69 patients died during follow-up in the report by
Otterstad et al. (8). Four of these deaths were suspected to
be VSD related (one bacterial aortic valve endocarditis;
three heart failure). In the series reported by Neumayer et al.
(9), three deaths occurred in 188 patients. Two patients died
suddenly and one died from gram-negative septicemia.
LV volume overload and pulmonary vascular disease. It
has previously been reported (3,4,7) that patients with small
VSDs are unlikely to develop pulmonary hypertension, and
shunt flow is unlikely to increase with advancing age. For
the latter, shunt flow has even been observed to decrease.
However, although PAP can be measured with satisfying
accuracy even by echocardiography, shunt flow and LV
volume load are more difficult to assess and may be
underestimated in some patients, particularly when a single
evaluation is performed in the specialized center. One might
suspect that at least in a part of those patients who present
with LV dilation and/or congestive heart failure at late
follow-up, volume overload was originally underestimated.
Figure 3. Exercise capacity (% of expected) in 140 patients who underwent
bicycle exercise testing.
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Indeed, 5% of patients in the series by Otterstad et al. (8)
were eventually found to have significant left-to-right shunt.
In the Second Natural History Study (NHS–2) (2),
patients with normal pulmonary vascular resistance but
significant shunt flow had a significantly worse outcome
compared to patients with small shunts. Shunt-flow calcu-
lations regardless of the method used are prone to signifi-
cant error, and the LV should, therefore, be carefully
evaluated for signs of volume overload. Patients with bor-
derline findings should be carefully followed. Based on
currently available data (2,8,9) we believe that patients with
signs of volume overload should undergo surgery even in the
absence of pulmonary hypertension or symptoms.
Aortic regurgitation. Development of AR or presence of
AR at late follow-up has been reported within the wide
range of 2% to 20% in previous studies (2,7–9,13). This
variety is not surprising, AR can be directly related to the
VSD. This is mainly the case in outlet defects (supracristal/
infracristal) but can also occur in perimembranous defects
(8,14,15). Patients with obvious prolapse of an aortic cusp
into the VSD have the highest risk of developing progres-
sive AR (14). Thus, there is consensus that outlet VSDs
together with aortic valve prolapse and all VSDs with
directly related AR that is more than trivial, particularly
when progression of AR is observed, should be corrected
even if the defect is small (16,17). In studies that excluded
patients with AR at presentation such as the NHS–2 (2),
development of AR at follow-up was rarely observed (2%).
However, 8 of these 12 patients had developed AR after
VSD closure, emphasizing that AR in patients with VSD is
not always directly related to the VSD itself but rather a
consequence of associated lesions such as bicuspid valve,
subaortic stenosis, and abnormalities of the ascending aorta. It
is not surprising that, in these cases, development or progres-
sion of AR cannot be prevented by VSD closure (2,15).
Endocarditis. The occurrence of endocarditis has been
described as the major risk in small VSDs (1,4,13). Again,
the incidence of this complication varies widely in previous
reports, ranging from 1% to 15% (2,3,8,9,13). Variations
reflect the difficulty of estimating the true incidence of this
complication (3). Shah et al. (18) estimated the risk of a
15-year-old with a VSD developing bacterial endocarditis
by age 70 to be 11.5%. Corone et al. (7) followed 790
patients for 25 years and reported endocarditis in 3.7% (2.4
per 1,000 patient-years). The highest percentage of 15%
(5.7 per 1,000 patient-years) was reported by Otterstad et al.
(13) for a heterogeneous group of 109 patients with a high
percentage of AR.
In contrast, bacterial endocarditis occurred rarely in
patients with small VSDs in the NHS–2 (1.3 per 1,000
patient-years) (2). Similarly, Keith et al. (3) reported endo-
carditis to occur infrequently in early adult life. Based on the
NHS–2 data, Gersony et al. (19) reported that the incidence
of endocarditis was significantly less after VSD closure but
not eliminated, whereas Kidd and associates (2) reported
from the same study an endocarditis rate of 1.4 versus 1.6
per 1,000 patient-years for nonoperated and postoperative
follow-up, respectively. The fact that they excluded patients
with additional AR may explain the discrepant results, and
it highlights the fact that endocarditis is in part related to
additional valvular disease in this patient population. In our
series, endocarditis infrequently occurred (1.8% or 2.4 per
1,000 patient-years), and one patient with aortic valve
endocarditis had a bicuspid valve; another patient with mitral
valve endocarditis had mitral valve prolapse with regurgitation.
Residual VSD and valvular disease after surgery may explain
why patients remain at risk of endocarditis even after VSD
closure. Thus, although endocarditis is definitely a matter of
concern in VSD patients, the risk of endocarditis alone may
not justify the need to close all small VSDs (20).
Spontaneous defect closure. The high chance of sponta-
neous closure is one of the major reasons why small VSDs
are followed conservatively (5,20). Reported closure rates
vary with size and location of VSD, age at presentation and
patient population. Alpert et al. (21) reported that small
VSDs have a 50% chance of spontaneous closure by five
years of age and a greater than 80% chance by adolescence.
Spontaneous closure becomes less likely during adolescence
and adult life. In 74 patients over 21 years of age (including
38 patients with small defects) admitted to the NHS–1 (22),
only one closure was observed. In NHS–2 (2), spontaneous
closure was reported in 15% of patients. In the study by
Neumayer et al. (9), spontaneous closure occurred in 10% of
patients, similar to our finding of 6%.
Arrhythmia. A higher-than-normal prevalence of arrhyth-
mias in patients with VSD has previously been reported. In
NHS–2 (2), 14% of medically managed patients had mul-
tiform premature ventricular contractions; 8% had couplets;
ventricular tachycardias were seen in 3%, and even sudden
death was reported. However, it is not specified how many
of these patients had small VSDs. Neumayer et al. (9)
reported 9% of patients in their series had supraventricular
and ventricular arrhythmias. These numbers are similar to
ours. The tendency to develop arrhythmias cannot be
expected to be positively affected by surgery. In NHS–2 (2),
the prevalence of arrhythmias was even significantly higher
in surgically treated patients. Houyel et al. (23) also reported
arrhythmias to be frequent after surgical VSD closure.
Thus, the occurrence of arrhythmias is a possible compli-
cation in patients with VSD, but cannot be avoided by
surgical repair and is even more likely after surgery.
Quality of life and socioeconomic considerations. In the
present study, only 5% of patients reported mild symptoms,
whereas 95% were asymptomatic. Similarly, in NHS–2 (2),
94% of patients with small VSDs were in New York Heart
Association functional class I. Backer et al. in their study
(10) argue that a definite socioeconomic stigma is associated
with living with an uncorrected cardiac defect. Patients may
not be allowed or may hesitate themselves to participate
freely in physical education and sports and may have
difficulty obtaining health and life insurance. In view of the
low risk of repair in the era of modern cardiac surgery, the
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investigators use this as one of the arguments to consider
surgery even in patients with small VSDs (10). However,
the fact of having had cardiac surgery and the fact of having
a median sternotomy scar may cause psychological problems
in itself and operation does not replace the need for
communication with the insurance company or the physical
education teacher (20). In addition, patients with a small
VSD should have no restrictions placed on physical activi-
ties, and there is no evidence that competitive sports are
more dangerous with a small VSD than with an intact
septum nor do data confirm the safety of competitive sports
after surgery. Thus, possible “socioeconomic stigma” cannot
be accepted as an argument for rigorous VSD closure.
Study limitations. Although most patients in this study
were sent to the adult unit by the Department of Pediatric
Cardiology where they had been followed regardless of how
small the defect was, some selection bias cannot be ex-
cluded. However, if anything, this bias would likely be
weighted toward sicker or more symptomatic patients. If
such a referral bias were indeed present, it would only mean
that the outcome of the overall population of patients with
small VSDs would be even better than reported.
Another limitation of the present study is that only 62%
of patients agreed to have exercise testing, and only 57%
agreed to have Holter monitoring. This may have affected
the results on exercise capacity and the occurrence of arrhyth-
mias. However, patients who are not totally asymptomatic or
do not feel entirely healthy are in general more likely to agree
to further testing. Thus, if there is any bias, this should have
worsened the results rather than improved them.
A major limitation of the present study is that many of
our patients are still young adults, and problems may
increase with advancing age. However, although average age
at last follow-up was significantly higher in the series by
Otterstad et al. (8), it was very similar in the study by
Neumayer et al. (9), the second previous report with
markedly worse patient outcome compared to the one in our
population. Nevertheless, we will continue to follow these
patients carefully to learn about outcome at advanced age.
Conclusions. The results of the present study confirm that
it is safe to withhold surgery in patients with an isolated
small VSD as long as patients are carefully selected and
carefully followed in a specialized congenital heart disease
program. Surgery does not appear to be required as long as
left-to-right shunt is definitely50% and signs of LV volume
overload are absent, when pulmonary pressure is not elevated,
and no VSD-related AR and/or symptoms are present.
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